ENSEM Therapeutics
- Founded: 2021
- Location: Waltham, MA
- Employee range: 11 - 50
- Clinical stage: RD
- Therapy area: Oncology
- Drug types: ONC
- Lead product: Undisclosed
- Product link: https://ensemtx.com/
- Funding: $67M A Apr 2022
- Investors: GGV Capital, Pavilion Capital, Cenova Capital, Mitsui & Co. Global Investment, Inc., CBC Group
ensemtx.com linkedin.com job board
Short description:
Characterizing rare conformational states in drug targets
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
ENSEM Therapeutics is developing precision drugs for oncology targets to address unmet clinical needs. To address oncology, non-obvious binding pockets on difficult-to-drug targets need to be found. Through the use of computational and AI deep learning methodologies combined with advanced experimental techniques, ENSEM has created their Kinetic Ensemble ® platform that identifies cryptic binding pockets and accelerates structure-based drug design. The platform uses data from multiple sources including clinical, imaging, molecular and multi-omics. ENSEM can use their approach to develop innovative small molecule precision medicines for oncology with the potential of targeting other diseases and genetic disorders.
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com